Posterior Capsule Opacification Study
Cataract
About this trial
This is an interventional treatment trial for Cataract focused on measuring Double-Blind Method, Clinical Trials, Randomized, Lenses, Intraocular, Prospective Studies, PMMA, Visual acuity
Eligibility Criteria
Inclusion Criteria: Age 40 to 65 years Bilateral senile cataract Pupil should be at least 7mm dilated Nuclear sclerosis grade I, II and III Patient willing for second eye surgery within 3 months Exclusion Criteria: Debilitated old patients Cardiac and serious illness Intraoperative complications including PC rent, Zonular dialysis and Rhexis tear Inherent zonular weakness Glaucoma patients Relative afferent papillary defect (RAPD) Shallow anterior chamber Pseudoexfoliation Traumatic cataract Uveitis and complicated cataract One eyed patients Corneal pathology Post segment pathology including diabetic retinopathy Dense Posterior subcapsular cataract (PSCC) and Posterior polar cataract (PPC) High myopic and hyperopic patient
Sites / Locations
- Aravind Eye Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Active Comparator
Experimental
Active Comparator
Arm 1 A - Square edge PMMA IOL
1B
2A
2B
50 patientes will recieve square edge PMMA IOL
In group 1, 50 eyes will receive round edge PMMA IOL
In group 2, 50 eyes will receive square edge PMMA IOL
In group 2, 50 eyes will receive acrysof IOL